Dmitry Dobrovolskiy
Lawyers
Filters
Zebra Technologies $500 million senior notes offering
The high-yield notes are due 2032
Cencosud $650 million senior notes offering
The senior notes are due 2031
Intra-Cellular Therapies $500 million stock offering
The shares are listed on the Nasdaq Global Select Market
Sabre $235 million accounts receivable securitization facility
We advised Sabre on the facility
Exchange transaction for Sabre exchangeable notes
We advised Sabre on its exchange of exchangeable senior notes
Gran Tierra Energy $100 million notes offering
The 9.5% senior notes are due 2029
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Gran Tierra Energy exchange offer and consent solicitations
The exchange offer included the issuance of new senior secured notes due 2029
Roivant Sciences registered direct offering and investment in Immunovant
We advised Roivant on the transactions
Equinix CHF 300 million bond offering
We advised Equinix on a Regulation S bond offering